IvelinRadkov/iStock via Getty Images
Avidity Biosciences (NASDAQ:RNA) has announced new data from its clinical trials evaluating the experimental treatment del-zota for Duchenne muscular dystrophy.
After one year of continuous treatment, participants showed not only a halt in disease progression, but also measurable improvements compared to their
The combined market valuation of six of the top-10 valued firms climbed Rs 63,478.46 crore last week, led by Larsen...
NASA is preparing to remove its massive moon rocket from its launchpad to fix a technical issue, delaying the agency’s much-anticipated mission...
The Justice Department’s investigation of Netflix Inc.’s proposed $72 billion takeover of Warner Bros. Discovery Inc. includes scrutiny of the...
Less than 24 hours after President Donald Trump signed an order establishing a new 10% global tariff, he announced an...
For months, futures markets have priced in just two quarter-percentage-point cuts this year from the Federal Reserve. Such rate cuts...
The latest twist in the U.S. tariff roller coaster ride, launched when President Donald Trump returned to office 13 months ago...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.
